鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/10/12 | 2,565 | 2,606 | 2,544 | 2,564 | -1 | ±0% | 52,000 |
2018/10/11 | 2,555 | 2,575 | 2,510 | 2,565 | -70 | -2.7% | 74,600 |
2018/10/10 | 2,712 | 2,712 | 2,625 | 2,635 | -94 | -3.4% | 81,700 |
2018/10/09 | 2,776 | 2,776 | 2,700 | 2,729 | -59 | -2.1% | 46,000 |
2018/10/05 | 2,748 | 2,810 | 2,728 | 2,788 | +39 | +1.4% | 41,700 |
2018/10/04 | 2,740 | 2,758 | 2,709 | 2,749 | +27 | +1% | 49,900 |
2018/10/03 | 2,652 | 2,734 | 2,652 | 2,722 | +70 | +2.6% | 43,700 |
2018/10/02 | 2,667 | 2,695 | 2,643 | 2,652 | -65 | -2.4% | 65,100 |
2018/10/01 | 2,725 | 2,767 | 2,703 | 2,717 | -18 | -0.7% | 45,700 |
2018/09/28 | 2,747 | 2,787 | 2,705 | 2,735 | +16 | +0.6% | 56,600 |
2018/09/27 | 2,731 | 2,731 | 2,659 | 2,719 | -14 | -0.5% | 82,600 |
2018/09/26 | 2,741 | 2,771 | 2,700 | 2,733 | +2 | +0.1% | 40,000 |
2018/09/25 | 2,668 | 2,731 | 2,663 | 2,731 | +95 | +3.6% | 104,400 |
2018/09/21 | 2,581 | 2,650 | 2,581 | 2,636 | +46 | +1.8% | 77,100 |
2018/09/20 | 2,678 | 2,678 | 2,581 | 2,590 | -72 | -2.7% | 80,600 |
2018/09/19 | 2,709 | 2,709 | 2,648 | 2,662 | -29 | -1.1% | 100,100 |
2018/09/18 | 2,632 | 2,692 | 2,595 | 2,691 | +60 | +2.3% | 79,300 |
2018/09/14 | 2,602 | 2,673 | 2,595 | 2,631 | +55 | +2.1% | 118,200 |
2018/09/13 | 2,579 | 2,590 | 2,553 | 2,576 | +18 | +0.7% | 74,800 |
2018/09/12 | 2,471 | 2,559 | 2,454 | 2,558 | +88 | +3.6% | 118,600 |
2018/09/11 | 2,423 | 2,490 | 2,422 | 2,470 | +55 | +2.3% | 94,200 |
2018/09/10 | 2,409 | 2,420 | 2,391 | 2,415 | +6 | +0.2% | 68,300 |
2018/09/07 | 2,347 | 2,409 | 2,341 | 2,409 | +59 | +2.5% | 134,000 |
2018/09/06 | 2,342 | 2,364 | 2,331 | 2,350 | +11 | +0.5% | 49,300 |
2018/09/05 | 2,300 | 2,350 | 2,292 | 2,339 | +31 | +1.3% | 77,700 |
2018/09/04 | 2,334 | 2,336 | 2,305 | 2,308 | -23 | -1% | 85,400 |
2018/09/03 | 2,375 | 2,375 | 2,330 | 2,331 | -37 | -1.6% | 104,200 |
2018/08/31 | 2,358 | 2,385 | 2,352 | 2,368 | +7 | +0.3% | 76,600 |
2018/08/30 | 2,366 | 2,383 | 2,345 | 2,361 | -1 | ±0% | 153,000 |
2018/08/29 | 2,357 | 2,370 | 2,350 | 2,362 | +2 | +0.1% | 210,300 |
2018/08/28 | 2,403 | 2,425 | 2,343 | 2,360 | -343 | -12.7% | 491,200 |
2018/08/27 | 2,701 | 2,707 | 2,663 | 2,703 | +2 | +0.1% | 13,100 |
2018/08/24 | 2,742 | 2,743 | 2,681 | 2,701 | -17 | -0.6% | 18,700 |
2018/08/23 | 2,713 | 2,749 | 2,703 | 2,718 | +3 | +0.1% | 22,000 |
2018/08/22 | 2,621 | 2,717 | 2,621 | 2,715 | +97 | +3.7% | 35,700 |
2018/08/21 | 2,602 | 2,623 | 2,597 | 2,618 | -13 | -0.5% | 13,800 |
2018/08/20 | 2,620 | 2,631 | 2,605 | 2,631 | ±0 | ±0% | 13,900 |
2018/08/17 | 2,630 | 2,648 | 2,612 | 2,631 | +1 | ±0% | 15,600 |
2018/08/16 | 2,633 | 2,664 | 2,604 | 2,630 | -35 | -1.3% | 25,100 |
2018/08/15 | 2,649 | 2,667 | 2,617 | 2,665 | -2 | -0.1% | 21,200 |
2018/08/14 | 2,599 | 2,667 | 2,598 | 2,667 | +60 | +2.3% | 29,800 |
2018/08/13 | 2,576 | 2,614 | 2,576 | 2,607 | +18 | +0.7% | 28,000 |
2018/08/10 | 2,604 | 2,606 | 2,567 | 2,589 | -5 | -0.2% | 28,400 |
2018/08/09 | 2,568 | 2,598 | 2,557 | 2,594 | +20 | +0.8% | 20,800 |
2018/08/08 | 2,608 | 2,625 | 2,573 | 2,574 | -59 | -2.2% | 20,100 |
2018/08/07 | 2,561 | 2,634 | 2,561 | 2,633 | +76 | +3% | 25,300 |
2018/08/06 | 2,555 | 2,587 | 2,554 | 2,557 | -32 | -1.2% | 32,900 |
2018/08/03 | 2,611 | 2,627 | 2,583 | 2,589 | -33 | -1.3% | 35,000 |
2018/08/02 | 2,629 | 2,684 | 2,608 | 2,622 | -29 | -1.1% | 34,300 |
2018/08/01 | 2,649 | 2,695 | 2,649 | 2,651 | -48 | -1.8% | 60,600 |
1651~
1700
件表示中 / 3745件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 162,000円 | +5.0% | +1.5% | 0.00% | 13.86倍 | 3.69倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 422,000円 | +3.6% | +6.1% | 2.84% | 14.22倍 | 0.84倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 385,000円 | -6.4% | -71.8% | 4.94% | 43.00倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 320,500円 | +7.9% | -3.3% | 2.50% | 8.91倍 | 0.92倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム